Nordiazepam

Nordazepam is a 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used mainly in the treatment of anxiety. Among its listed roles, it functions as a anxiolytic drug, an anticonvulsant, a sedative, a GABA modulator and a human metabolite. It is a 1,4-benzodiazepinone and an organochlorine compound. Nordiazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance. An intermediate in the metabolism of Diazepam to Oxazepam. It may have actions similar to those of diazepam. Nordiazepam is a metabolite of Diazepam. Diazepam, first marketed as Valium by Hoffmann-La Roche, is a benzodiazepine drug. Nordazepam, also known as desoxydemoxepam, nordiazepam and desmethyldiazepam, is a 1,4-benzodiazepine derivative. Like other benzodiazepine derivatives, it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties. It is grouped under the following drug class(es): Anxiolytics, Benzodiazepines and Schedule IV controlled substances. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Nordazepam, desmethyldiazepam and Norprazepam. It is also listed for alternate use as: API Impurity. Its PubChem CID is 2997.

CAS No 1088-11-5
Molecular Formula C15H11ClN2O
Molecular Weight 270.71 g/mol
Synonyms 7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one

Frequently Asked Questions